Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
US Army
Julphar
Merck
Johnson and Johnson
Federal Trade Commission
Fuji
Dow
Cipla

Generated: July 18, 2018

DrugPatentWatch Database Preview

Polythiazide - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for polythiazide and what is the scope of polythiazide freedom to operate?

Polythiazide
is the generic ingredient in three branded drugs marketed by Pfizer and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for polythiazide.
Summary for polythiazide
US Patents:0
Tradenames:3
Applicants:1
NDAs:3
Drug Master File Entries: 1
Bulk Api Vendors: 18
Patent Applications: 4,307
DailyMed Link:polythiazide at DailyMed
Medical Subject Heading (MeSH) Categories for polythiazide
Synonyms for polythiazide
2-Methyl-3-(beta,beta,beta-trifluoroethylthiomethyl)-6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-2-methyl-3-(((2,2,2-trifluoroethyl)thio)methyl)-, 1,1-dioxide
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-2-methyl-3-(((2,2,2-trifluoroethyl)thio)methyl)-, 1,1-dioxide (8CI, 9CI)
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-2-methyl-3-[[(2,2,2-trifluoroethyl)thio]methyl]-, 1,1-dioxide
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-2-methyl-3-[[(2,2,2-trifluoroethyl)thio]methyl]-, 1,1-dioxide (8CI, 9CI)
2H-1,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-2-methyl-3-[[(2,2,2-trifluoroethyl)thio]methyl]-, 1,1-dioxide
346-18-9
6-chloro-2-methyl-1,1-dioxo-3-(2,2,2-trifluoroethylsulfanylmethyl)-3,4-dihydro-1
6-chloro-2-methyl-1,1-dioxo-3-(2,2,2-trifluoroethylsulfanylmethyl)-3,4-dihydro-1?^{6},2,4-benzothiadiazine-7-sulfonamide
6-chloro-2-methyl-1,1-dioxo-3-(2,2,2-trifluoroethylsulfanylmethyl)-3,4-dihydrobenzo[e][1,2,4]thiadiazine-7-sulfonamide
6-chloro-2-methyl-1,1-dioxo-3-{[(2,2,2-trifluoroethyl)sulfanyl]methyl}-3,4-dihydro-2H-1$l;{6},2,4-benzothiadiazine-7-sulfonamide
6-Chloro-2-methyl-3-([(2,2,2-trifluoroethyl)sulfanyl]methyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide #
6-CHLORO-2-METHYL-3-[[(2,2,2-TRIFLUOROETHYL)SULFANYL]METHYL]-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE
6-chloro-2-methyl-3-{[(2,2,2-trifluoroethyl)thio]methyl}-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
6-Chloro-3,2,2-trifluoroethyl)thio]methyl]-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
6-Chloro-3,4-dihydro-2-methyl-3-(((2,2,2-trifluoroethyl)thio)methyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
6-Chloro-3,4-dihydro-2-methyl-3-[[(2,2,2-trifluoroethyl)thio]methyl]-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
6-Chloro-3,4-dihydro-2-methyl-7-sulphamoyl-3-(2,2,2-trifluoroethylthiomethyl)-2H-benzo-1,2,4-thiadiazine 1,1-dioxide
AC1L1J55
AC1Q6TPT
ACM346189
API0006930
BRN 0770371
C07766
C11H13ClF3N3O4S3
CAS-346-18-9
CCRIS 6094
CHEBI:8327
CHEMBL1587
CYLWJCABXYDINA-UHFFFAOYSA-N
D00657
D06TNG
DB01324
Drenusil
DSSTox_CID_5939
DSSTox_GSID_25939
DSSTox_RID_77972
EINECS 206-468-4
FT-0673974
GTPL7274
HE068604
HE337049
HSDB 850
KS-1466
LS-1223
NCGC00182076-02
NCGC00182076-03
Nephril
NSC 108161
NSC-108161
NSC108161
P 2525
P-2525
Politiazida
Politiazida [INN-Spanish]
POLYTHIAZIDE (200 MG)
Polythiazide (JAN/USAN/INN)
Polythiazide [USAN:INN:BAN:JAN]
Polythiazidum
Polythiazidum [INN-Latin]
Renese
Renese (TN)
SCHEMBL27909
SR-01000883970
SR-01000883970-1
Tox21_113137
Tox21_113137_1
WLN: T66 BSWN EM DHJ C1 D1S1XFFF HG ISZW

US Patents and Regulatory Information for polythiazide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer RENESE polythiazide TABLET;ORAL 012845-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer RENESE polythiazide TABLET;ORAL 012845-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer MINIZIDE polythiazide; prazosin hydrochloride CAPSULE;ORAL 017986-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer RENESE-R polythiazide; reserpine TABLET;ORAL 013636-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
QuintilesIMS
Cipla
Citi
Julphar
Express Scripts
Dow
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.